Omega Healthcare Investors Inc (OHI) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of Omega Healthcare Investors Inc stock $57.75, price $47.99, upside +20.3%, quality 49 out of 100. Rating: undervalued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range $18.21 – $51.03 · fair‑value band $25.55 – $101.77 · the $47.99 price screens below the $57.75 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Omega Healthcare Investors in your weekly email
Every Wednesday you see whether Omega Healthcare Investors is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom.
Show moreShow less
As of September 30, 2025, Omega has a portfolio of investments that includes 1,024 operating facilities located in 42 states, the District of Columbia and the United Kingdom/Jersey (290 facilities) and operated by 88 different operators.
Additionally, Omega has investments in several unconsolidated entities that own 19 facilities. As a source of capital to the healthcare industry, Omega continually evaluates the opportunities, trends and challenges affecting the industry.
Our goal is to identify long-term investments in quality healthcare properties with outstanding operators that provide the most favorable risk/reward ratio to our investors. Omega Healthcare Investors, Inc. is based in Hunt Valley, United States.
Stock analysis
Omega Healthcare Investors Inc (OHI) currently trades at $47.99, while our model-based Fair Value estimate is $57.75, implying the stock looks roughly 17% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $79.46 per share, and 5 of the 15 models we run sit above the $47.99 price.
Bear case: the Asset-Based group reads lowest at $9.97, and 10 of the 15 models stay below the price. Data coverage for this calculation is high.
Scenario range: $25.55 (bear) to $101.77 (bull), the price of $47.99 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Real Estate sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Omega Healthcare Investors Inc reported revenue of $1.2B in FY2025 versus $1.1B in FY2021, a compound +3.0%/yr. Reported net income was $590M in FY2025, compounding +9.1%/yr from FY2021.
Key figures
Market cap $15.2B Large · P/E ratio 16.8 · P/S ratio 12.0 · EPS (TTM) $2.83 · Dividend yield 5.6% · Net margin 68.1% · Return on equity 16.5% · Return on assets (EBIT) 5.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 71 out of 100 (medium confidence).
What moves the price
The share trades about 6% below its 52-week high and 17% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −20% fair-value upside, at 20%, OHI screens cheaper than that median.
Fair Value models
Bear$25.55Fair Value $57.75Bull$101.77
Price $47.99 · Upside +20.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($0.1189 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, no officer or director bought or sold shares on the open market.
BuyVikas GuptaChief Investment Officer11,500 shares at $42.97$494,155Nov 6, 2025
Plus 6 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+14.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
Start year 2020 (pandemic). Over 10 years: +4.9% a year
Revenue growth 33 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+10.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.9%
Dividend (yield on the price)5.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.4.3% vs 0.9%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.51% → 63%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+7.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +4.8% a year for the price and +0.6% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (88 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: Stable cash flows from active transitions to stronger operators form the main strength of this healthcare REIT, while limited differentiation and dependence on operator performance remain its core weakness.
Main risk: Changes in Medicare and Medicaid reimbursement rates or new rules on healthcare facility operations could reduce operators' margins and their ability to meet lease obligations.
Bull case: The company could strengthen operator selection and relationships while engaging with policymakers to shape balanced rules, preserving access to attractive healthcare properties.
Bear case: If restrictive laws pass or reimbursement pressures intensify, the company might face fewer investment options and greater difficulty collecting stable rents from operators.
Omega actively manages its portfolio by transitioning operators on key assets to stronger ones. The recent shift of 32 Florida facilities to PACS brings scheduled annual rent increases starting at more than twenty-six million dollars after a one-time expense. Our models see it as undervalued, yet this shows the tension between locking in better long-term cash flows from capable operators and handling near-term costs in a business that depends on their performance. Does the rent uplift from such moves strengthen the REIT more than it exposes it to operator transition risks?
Compare Omega Healthcare Investors Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.REIT - Healthcare Facilities · 25 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Omega Healthcare Investors Inc (OHI) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of $57.75 versus a price of $47.99, about +20% upside (undervalued).
What is the fair value of OHI?
Our model-based fair value for Omega Healthcare Investors Inc is $57.75 (as of Nov 4, 2026), built from audited fundamentals. The current price: $47.99.
What is the quality score of OHI?
Omega Healthcare Investors Inc has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Omega Healthcare Investors Inc (OHI)?
Our model-based price target is the fair value of $57.75 (as of Nov 4, 2026) from 15 valuation models. Cautious scenario $25.55, optimistic scenario $101.77. It is a calculation from audited fundamentals, not an analyst target.
What is the Omega Healthcare Investors Inc stock forecast for 2026?
Our models put fair value at $57.75, about +20% upside versus a price of $47.99 (undervalued). Cautious scenario $25.55, optimistic scenario $101.77. The calculation is refreshed regularly with new filings.
What is the revenue of Omega Healthcare Investors Inc (OHI)?
Omega Healthcare Investors Inc reported trailing-twelve-month revenue of about $1.3B (latest available figure, as of Nov 4, 2026).
Does Omega Healthcare Investors Inc pay a dividend?
Omega Healthcare Investors Inc currently shows a dividend yield of 5.61% relative to its recent price (as of Nov 4, 2026).
What growth is priced into Omega Healthcare Investors Inc (OHI)?
For today's price to be fair in a discounted-cash-flow model, Omega Healthcare Investors Inc would have to grow free cash flow by +7.3 % per year for five years (discount rate 8.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.1 % per year. As of Nov 4, 2026.
What discount rate (WACC) does the fair value of OHI use?
Our models discount Omega Healthcare Investors Inc at 8.2 %: a base by market capitalisation (large), damped by beta 0.55, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Omega Healthcare Investors Inc that is +7.3 % per year a year over ten years, using the same discount rate (8.2 %) and the same formula as our fair value.
How much growth has Omega Healthcare Investors Inc (OHI) delivered so far?
Over the past 5 years revenue at Omega Healthcare Investors Inc grew +6.1 % a year. The price currently implies +7.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Omega Healthcare Investors Inc (OHI) growing?
The median revenue growth in the sector is +2.7 % a year. That is the yardstick for the growth priced into Omega Healthcare Investors Inc (+7.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Omega Healthcare Investors Inc (OHI)?
The free-cash-flow yield on the price is 5.79 %: that much free cash flow Omega Healthcare Investors Inc produces per unit of market value. When it exceeds the discount rate of our models (8.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Omega Healthcare Investors Inc (OHI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Omega Healthcare Investors Inc it is $57.75 per share (as of Nov 4, 2026), against a price of $47.99. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is Omega Healthcare Investors Inc stock overvalued or undervalued in 2026?
As of Nov 4, 2026, OHI trades below its calculated fair value: price $47.99, fair value $57.75, a gap of about +20% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of OHI?
No. The price is what the market pays today ($47.99); the fair value is what the company's own numbers justify ($57.75). For Omega Healthcare Investors Inc the two are $9.76 per share apart. That gap is exactly why we show both numbers side by side.
How much is Omega Healthcare Investors Inc worth?
The market values Omega Healthcare Investors Inc at about $15.2B (market capitalisation, as of Nov 4, 2026). Per share that is $47.99; our models calculate a fair value of $57.75 per share.
What do the bullish and bearish scenarios say about OHI?
Our models span a range for Omega Healthcare Investors Inc: cautious scenario $25.55, base $57.75, optimistic $101.77 per share (as of Nov 4, 2026, price $47.99). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of OHI?
Omega Healthcare Investors Inc trades at a price-to-earnings ratio of 16.8 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $57.75 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, 5 of the years ex one-offs: 24.2. Other multiples: PEG 12.0, P/B 2.9, P/S 12.0, EV/EBITDA 17.0.
What is the PEG ratio of OHI?
The PEG ratio of Omega Healthcare Investors Inc is 11.99 (P/E divided by earnings growth, as of Nov 4, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Omega Healthcare Investors Inc (OHI)?
Balance-sheet figures for Omega Healthcare Investors Inc (as of Nov 4, 2026): return on equity 16.5%, debt of 0.82 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is OHI from its 52-week high?
Omega Healthcare Investors Inc trades at $47.99, about 6% below its 52-week high of $51.03 and 17% above the low of $40.84 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of $57.75 is for.
Which stocks are comparable to Omega Healthcare Investors Inc?
From the same area (Real Estate) we also value Welltower Inc, Ventas, Inc, Healthpeak Properties, Inc, American Healthcare REIT, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Omega Healthcare Investors Inc stock attractive at the current price?
The data as of Nov 4, 2026: price $47.99, calculated fair value $57.75 (+20%), Quality Score 49/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of OHI calculated?
We run Omega Healthcare Investors Inc through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $57.75, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Omega Healthcare Investors Inc currently trades 17% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Omega Healthcare Investors Inc (OHI)?
The closing price on Nov 5, 2026 was $47.99. Our model-based fair value is $57.75, about +20% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Omega Healthcare Investors Inc right now?
The model range is unusually wide ($25.55 to $101.77). The outcome hinges heavily on assumptions, so read the point estimate with caution. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Where does the earnings growth of Omega Healthcare Investors Inc (OHI) come from?
Earnings per share at Omega Healthcare Investors Inc grew −0.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share −1.0 %, EBIT margin −0.4 %, tax rate +1.4 %, residual (interest, one-offs) −0.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Omega Healthcare Investors Inc
How large is the market capitalisation of Omega Healthcare Investors Inc (OHI)?
The market capitalisation of Omega Healthcare Investors Inc is $15.2B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Omega Healthcare Investors Inc (OHI)?
The price-to-sales ratio of Omega Healthcare Investors Inc is 12.0 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Omega Healthcare Investors Inc (OHI)?
Earnings per share at Omega Healthcare Investors Inc are $2.83 (price ÷ EPS = P/E 16.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Omega Healthcare Investors Inc (OHI)?
The dividend yield of Omega Healthcare Investors Inc is 5.6% (payout 95.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Omega Healthcare Investors Inc (OHI)?
The net margin of Omega Healthcare Investors Inc is 68.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Omega Healthcare Investors Inc (OHI)?
The return on equity (ROE) of Omega Healthcare Investors Inc is 16.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Omega Healthcare Investors Inc (OHI)?
On an EBIT basis the return on assets of Omega Healthcare Investors Inc is 5.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Omega Healthcare Investors Inc (OHI)?
The operating margin of Omega Healthcare Investors Inc is 61.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Omega Healthcare Investors Inc (OHI)?
Revenue at Omega Healthcare Investors Inc is growing +11.2% versus a year earlier (3y avg +10.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Omega Healthcare Investors Inc (OHI)?
Earnings per share at Omega Healthcare Investors Inc are growing +161% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Omega Healthcare Investors Inc (OHI) carry?
The net debt of Omega Healthcare Investors Inc is $4.2B (fiscal year 2025, ≈ 4.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Omega Healthcare Investors Inc in the live analysis
One click puts Omega Healthcare Investors Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 4, 2026